相关实验视频

Updated: Jun 5, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

一种自我级联的催化疗法和抗原捕获架构介导的T细胞增强用于术后脑免疫疗法

Bhanu Nirosha Yalamandala¹, Thrinayan Moorthy¹, Zhuo-Hao Liu^2,3,4

¹Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, 300044, Taiwan.

Small (Weinheim an der Bergstrasse, Germany)

|December 16, 2024

概括

这项研究为脑瘤免疫治疗引入了一种新的支架. 脚手架增强了T细胞对质母细胞瘤 (GBM) 复发的反应,改善了手术后的生存率.

科学领域:

生物医学工程生物医学工程
免疫治疗是一种免疫疗法.
在瘤学瘤学.

背景情况:

由于免疫特权和低疫苗免疫性,质母细胞瘤 (GBM) 复发的免疫治疗具有挑战性.
在脑瘤中,有限的T淋巴细胞透阻碍了有效的免疫反应,防止复发.

研究的目的:

开发一种可植入的支架,用于增强术后脑免疫疗法对抗质母细胞瘤.
为了改善T细胞招募和抗瘤免疫力在脑瘤微环境.

主要方法:

开发了一个3D打印的脚手架 (CAS),使用带有铁 (Fe2+) 金属有机框架 (MOFs) 和尿-聚乙烯糖醇-聚烯糖醇 (PU-EO-PO) 分段的弹性体.
酸盐启动芬顿反应以持续产生ROS,并与 (CQ) 抑制自以增强抗原释放.
CAS充当抗原储存,捕获瘤抗原,促进树突细胞成熟和T细胞激活.

主要成果:

在CAS支架上证明了催化疗效率的提高和持续的ROS生产.
抑制自增强瘤细胞细胞毒性和抗原释放.
脚手架有效捕获抗原,促进T细胞增强和持续的免疫刺激.

结论:

开发的CAS支架显示了增强手术后脑免疫疗法对抗质母细胞瘤的显著潜力.
这种方法在质母细胞瘤复发模型中改善了免疫反应和生存率.

关键词:

在T细胞,T细胞.捕获抗原捕获的方法催化疗法是一种催化疗法.免疫疗法免疫疗法手术后的大脑瘤

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.